Back to DE Deerfield Management Company, L.P.
ININTERCEPT PHARMAS
Showing 0 of 15 quarters
Position history for DEDeerfield Management Company, L.P.'s holdings in INTERCEPT PHARMAS
No. Deerfield Management exited its INTERCEPT PHARMAS position in Q2 2023. Its Q1 2023 13F listed 57,791,000 shares worth $57M. Deerfield Management held INTERCEPT PHARMAS in 14 quarterly 13F filings before exiting.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
—
No position history available for this security.